US Patent Issued to Celgene on March 31 for "Methods for screening cereblon modifying compounds" (California, New Jersey Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,953, issued on March 31, was assigned to Celgene Corp. (Summit, N.J.).

"Methods for screening cereblon modifying compounds" was invented by Mary Matyskiela (San Diego), Philip Chamberlain (San Diego), Suzana Sturlini Couto (La Jolla, Calif.), Katherine Stamp (Montclair, N.J.), Philip J. Sherratt (Scotch Plains, N.J.), Gang Lu (San Diego) and Julia Hui (Basking Ridge, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of screening a cereblon modifying compound for treating a disease or disorder, comprising: obtaining a sample; determining a first protein level of SALL4; administering the cereblon modifying compound to the sample; determini...